Ascend Capital’s Athenahealth, Inc. ATHN Stock Holding History

Ascend Capital’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-85,557	Closed	-$11.4M	–	296
2017 Q4	$11.4M	Buy	+85,557	New	+$10.9M	0.43%	71

Other funds holding ATHN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ascend Capital's ATHN Position: Q1 2018 in Review

Ascend Capital sold out of Athenahealth, Inc. (ATHN) in Q1 2018, closing a stake of 85,557 shares — an estimated $11.4M sold.

Ascend Capital first reported a position in ATHN in Q4 2017 and held it in 1 quarter. The position peaked at $11.4M in Q4 2017. 259 funds tracked by Wall St. Rank hold ATHN as of Q1 2018.

Ascend Capital reported no remaining Athenahealth, Inc. position as of Q1 2018 after selling out during the quarter.
Ascend Capital sold 85,557 Athenahealth, Inc. shares in Q1 2018, an estimated $11.4M.
Ascend Capital first reported a position in Athenahealth, Inc. in Q4 2017 and held it in 1 quarter.
Ascend Capital's Athenahealth, Inc. position peaked at $11.4M in Q4 2017.
259 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.